Skip to main content
. Author manuscript; available in PMC: 2022 Apr 8.
Published in final edited form as: Circ Cardiovasc Imaging. 2021 Apr 8:CIRCIMAGING120011701. doi: 10.1161/CIRCIMAGING.120.011701

Table 3C:

Association of carotid plaque with cardiovascular disease events (N=2673)

Unadjusted Model 1 Model 2
HR (95% CI) P-value HR (95% CI) P-value HR (95% CI) P-value
Carotid Plaque 1.54
(1.12, 2.13)		 0.008 1.25
(0.90, 1.73)		 0.189 1.07
(0.76, 1.50)		 0.700
Age
(per 5-years) 		1.28
(1.17, 1.4)		 <0.001 1.26
(1.14, 1.38)		 <0.001
Male 1.24
(0.89, 1.73)		 0.195 1.05
(0.73, 1.50)		 0.805
Race (ref=White) 0.227 0.592
 Chinese 0.69
(0.36, 1.3)		 0.64
(0.34, 1.23)
 Black 1.28
(0.86, 1.88)		 0.96
(0.63, 1.45)
 Hispanic 1.16
(0.76, 1.78)		 0.97
(0.62, 1.51)
Diabetes 1.70
(1.06, 2.73)		 0.027
Smoking 2.64
(1.76, 3.95)		 <0.001
SBP
(per 10-mmHg) 		1.18
(1.09, 1.28)		 <0.001
Antihypertensive use 1.05
(0.72, 1.52)		 0.796
TC
(per 40-mg/dL) 		0.93
(0.77, 1.13)		 0.482
HDL-C
(per 5-mg/dL) 		0.95
(0.89, 1.01)		 0.110
Statin use 0.94
(0.57, 1.55)		 0.801

Cox proportional hazards regression models with carotid plaque as independent variable and time-to-cardiovascular disease event as dependent variable. Abbreviations same as Tables 1 and 2.